Stem cell therapy for Parkinson’s disease: safety and modeling

Stem cell therapy for Parkinson’s disease: safety and modeling

For decades, clinicians have developed medications and therapies to alleviate the symptoms of Parkinson’s disease, but no treatment currently can slow or even stop the progression of this localized neurodegeneration. Fortunately, sparked by the genetic revolution, stem cell reprogramming research an...

Full description

Bibliographic Details
Main Authors: Theo Stoddard-Bennett, Renee Reijo Pera
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Neural Regeneration Research
Subjects:
alpha synuclein; animal model; cell therapy; dopaminergic neurons; induced pluripotent stem cells; neurodegeneration; Parksinson’s disease; stem cells
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=1;spage=36;epage=40;aulast=Stoddard-Bennett

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=1;spage=36;epage=40;aulast=Stoddard-Bennett

Similar Items